Thrombophilia and first arterial ischaemic stroke: A systematic review

Archives of Disease in Childhood

Volumn 90, Issue 4, 2005, Pages 402-405

  Haywood, S ^a   Liesner, R ^b   Pindora, S ^a   Ganesan, V ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ACTIVATED PROTEIN C; ANTITHROMBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; HOMOCYSTEINE; PROTEIN C; PROTEIN S; PROTHROMBIN;

ACTIVATED PROTEIN C RESISTANCE; AMINO ACID BLOOD LEVEL; ANTITHROMBIN DEFICIENCY; ARTERIAL ISCHEMIC STROKE; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; GENE MUTATION; HIGH RISK POPULATION; HUMAN; MEDICAL LITERATURE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; RECURRENT DISEASE; REVIEW; SYSTEMATIC REVIEW; THROMBOPHILIA;

BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHILD; FACTOR V; HOMOCYSTEINE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTATION; ODDS RATIO; PROGNOSIS; THROMBOPHILIA;

EID: 16844383488     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2004.049163     Document Type: Review

References (28)

1. Broderick J, Talbot GT, Prenger E, et al. Stroke in children within a major metropolitan area: the surprising importance of intracerebral hemorrhage. J Child Neurol 1993;8:250-5.
2. Lanthier S, Carmant L, David M, et al. Stroke in children: the coexistence of multiple risk factors predicts poor outcome. Neurology 2000;54:371-8.
3. deVeber G, Monagle P, Chan A, et al. Prothrombotic disorders in infants and children with cerebral thromboembolism. Arch Neurol 1998;55:1539-43.
4. Ganesan V, McShane MA, Liesner R, et al. Inherited prothrombotic states and ischaemic stroke in childhood. J Neurol Neurosurg Psychiatry 1998;65:508-11.
5. McColl MD, Chalmers EA, Thomas A, et al. Factor V Leiden, prothrombin 20210G->A and the MTHFR C677T mutations in childhood stroke. Thromb Haemost 1999;81:690-4.
6. Altman DG, Egger M, Smith G. Systematic reviews in healthcare. Meta-analysis in context, 2nd edn. London: BMJ Publishing Group, 2001.
7. Ganesan V. The aetiology, investigation and outcome of ischaemic stroke in childhood. MD thesis, University of London, 1999.
8. Kah S, Chen LS. Protein C and S deficiency in children with ischemic cerebrovascular accident. Pediatr Neurol 1997;17:319-21.
9. Mahanty S, Saxena R, Behari M. Activated protein C (APC) resistance in young stroke patients. Thromb Haemost 1999;81:465-6.
10. Saxena R, Mohanty S, Jain Y. Activated protein C (APC) resistance in Indian children with thromboembolism. Br J Haematol 1999;105:314-15.
11. Nawak-Gättl U, Sträter R, Kosch A, et al. The plasminogen activator inhibitor (PAI)-1 promoter 4G/4G genotype is not associated with ischemic stroke in a population of German children. Childhood Stroke Study Group. Eur J Haematol 2001;66:57-62.
12. Kenet G, Sadetzki S, Murad H, et al. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke 2000;31:1283-8.
13. Kennedy CR, Warner G, Kai M, et al. Protein C deficiency and stroke in early life. Dev Med Child Neurol 1995;37:723-30.
14. Riikanen RS, Vahtero EM, Kekomäki RM. Physiological anticoagulants and activated protein C resistance in childhood stroke. Acta Paediatr 1996;85:242-4.
15. Nowak-Göttl U, Sträter R, Heinecke A, et al. Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood 1999;94:3678-82.
16. Uysal S, Anlar B, Altay C, et al. Role of protein C in childhood cerebrovascular occlusive accidents. Eur J Pediatr 1989;149:216-18.
17. Riikonen RS, Santavuori P. Hereditary and acquired risk factors for childhood stroke. Neuropediatrics 1994;25:227-33.
18. Akar N, Akar E, Özel D, et al. Common mutations at the homocysteine metabolism pathway and pediatric stroke. Thromb Res 2001;102:115-20.
19. Carda E, Vilaseca MA, Campistol J, et al. Evaluation of hyperhomocysteinaemia in children with stroke. Eur J Paediatr Neurol 1999;3:113-17.
20. Carda E, Monrós E, Colomé C, et al. Children with stroke: polymorphism of the MTHFR gene, mild hyperhomocysteinemia, and vitamin status. J Child Neurol 2000;15:295-8.
21. Vilaseca MA, Moyano D, Ferrer I, et al. Total homocysteine in pediatric patients. Clin Chem 1997;43:690-2.
22. van Beynum IM, Smeitink JAM, den Heijer M, et al. Hyperhomocysteinemia: a risk factor for ischemic stroke in children. Circulation 1999;99:2070-2.
23. Heller C, Becker S, Scharrer I, et al. Prothrombotic risk factors in childhood stroke and venous thrombosis. Eur J Pediatr 1999;158(suppl 3):S117-21.
24. Sträter R, Vielhaber H, Kassenbohmer R, et al. Genetic risk factors of thrombophilia in ischaemic childhood stroke of cardiac origin. A prospective ESPED survey. Eur J Pediatr 1999;158(suppl 3):S122-5.
25. Prengler M, Sturt N, Krywawych S, et al. Homozygous thermolabile variant of the methylenetetrahydrofolate reductase gene: a potential risk factor for hyperhomocysteinaemia, CVD, and stroke in childhood. Dev Med Child Neurol 2001;43:220-5.
26. Andrew M, David M, Adams M, et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian registry of VTE. Blood 1994;83:1251-7.
27. Sträter R, Becker S, von Eckardstein A, et al. Prospective assessment of risk factors for recurrent stroke during childhood - a 5-year follow-up study. Lancet 2002;360:1540-5.
28. Kirkham FJ, DeVeber GA, Chan AK, et al. Recurrent stroke: the role of prothrombotic disorders. Ann Neurol 2003;54(suppl 7):S110.